FDA panel votes for tougher curbs on vicodin, other painkillers

by Amanda Gardner, Healthday Reporter
FDA panel votes for tougher curbs on vicodin, other painkillers
Debate over the move has pitted patients in chronic pain against those fighting drug abuse.

(HealthDay)—A U.S. Food and Drug Administration advisory panel voted Friday to place tougher restrictions on prescription painkillers containing hydrocodone, potentially moving medications such as Vicodin into the same class as narcotics such as Oxycontin and Percocet.

Vicodin (hydrocodone plus ) and other hydrocodone-containing drugs remain widespread targets for abuse, and the U.S. has long requested that the FDA undertake the review. The panel spent two days discussing the issue before voting on Friday afternoon, the Associated Press reported.

Currently, the medications are classified as Schedule III drugs but the DEA wants them placed within the more tightly controlled Schedule II designation, alongside painkillers such as and Percocet.

The FDA is not required to follow the recommendations of its advisory panels, but it typically does.

The issue has become a contentious one.

Supporters of a move to Schedule II status point to tragic deaths and suicides that have been the result of misuse of these .

But, opponents of that tougher classification fear that tightening access to the drugs would mean that people who really need them to ease pain will not be able to get them.

"This is really a decision of access versus diversion [for non-medical use]," explained Dr. Lynn Webster, president-elect of the American Academy of Pain Medicine, who said his organization was not necessarily in favor of or opposed to reclassification.

However, "it will have an impact on a lot of patients who have been receiving them for some time for legitimate purposes" if these drugs are reclassified, Webster added.

Dr. Andrew Kolodny, president of Physicians for Responsible Prescribing, called such concerns "completely bogus."

"Even if we change hydrocodone-containing products from Schedule III to Schedule II, it in no way jeopardizes access," he believes. "What this means is that patients who might be able to go to their doctor every six months would now have to see their doctor every three months [to get a prescription]."

Kolodny also contends that "people who are on long-term opioids are more likely to be harmed by that treatment than helped. There is very little difference between a heroin molecule and a hydrocodone molecule."

Few people seem to dispute the fact that too many of these opioid drugs are too widely available, even though the pharmaceutical industry has recently developed "abuse-resistant" formulations to help fight misuse.

Overall, some 22 million Americans have misused prescription painkillers of one kind or another since 2002, according to a report released earlier this month by the U.S. Substance Abuse and Mental Health Services Administration. The agency noted that now rank only behind marijuana as a of abuse in the United States.

According to Webster, patients typically do not use two-thirds of the hydrocodone-containing medications they've been prescribed, meaning those leftover pills might become available for misuse.

"That suggests that there are way more drugs being prescribed than is necessary," Webster said. "And we know that basically 80 percent of all drugs used for non-medical purposes come from the medicine cabinet at home."

Added Kolodny, who is also chair of psychiatry at Maimonides Medical Center in New York City: "We have an epidemic of people with opioid addiction. That's what's really causing overdose deaths."

According to Kolodny, "changing hydrocodone-combination products from Schedule III to Schedule II may be the single most important federal intervention that could be taken to bring this epidemic under control."

Webster said he remained "seriously concerned about both of these issues [access and diversion]," but also felt that there were alternatives to reclassifying.

"We need more education about how to safely prescribe these drugs and identify people who are safe candidates and prescribe less," he said. "At the same time, we need a national campaign that informs the public and people who are receiving the medications that it's dangerous to have leftover medications and that they need to find ways to dispose of their medications or not accept a prescription."

More information: Visit the U.S. National Library of Medicine for more on prescription drug abuse.

add to favorites email to friend print save as pdf

Related Stories

Senator warns FDA on danger of newest painkillers

Jan 08, 2012

Following fatal shootings in two New York pharmacy robberies, a U.S. senator is warning that a new batch of "super painkillers" now under review could force repeats of recent violent robberies that left six people dead.

US panel opposes pure hydrocodone painkiller

Dec 09, 2012

(AP)—U.S. government health experts overwhelmingly voted against a stronger version of hydrocodone on Friday, questioning the need for a new form of one of most widely abused prescription painkillers.

Recommended for you

Study recalculates costs of combination vaccines

7 hours ago

One of the most popular vaccine brands for children may not be the most cost-effective choice. And doctors may be overlooking some cost factors when choosing vaccines, driving the market toward what is actually a more expensive ...

Drug watchdog urges vigilance in cancer drug theft

10 hours ago

Europe's medicine watchdog urged doctors Thursday to be vigilant in administering the cancer drug Herceptin, vials of which had been stolen in Italy and tampered with before being sold back into the supply chain.

Pyridoxine-doxylamine drug safety data lacking

Apr 16, 2014

(Medical Xpress)—The most commonly prescribed drug for pregnant women suffering from morning sickness in their first trimester does not prevent birth defects even though drug safety data says it does, according to research ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

Doug_Huffman
1 / 5 (1) Jan 26, 2013
Regulation of drugs is as effective as regulation of guns is as effective as regulation of all malum prohibitum.
jimh217
not rated yet Jan 29, 2013
I have been a pharmacist in the US for 55 years. During that time I have seen a rapid and sustained increase in laws and regulations concerning controlled substances. There has been no reduction in abuse. If anything, increased prohibition has resulted in an increase in illicit drug trade and drug related crime.